10-QPeriod: Q2 FY2015

AXON ENTERPRISE, INC. Quarterly Report for Q2 Ended Jun 30, 2015

Filed August 6, 2015For Securities:AXON

Summary

TASER International, Inc. (AXON) demonstrated robust top-line growth in the second quarter of 2015, with net sales increasing by 25.7% year-over-year to $46.7 million. This growth was driven by strong performance in both the TASER Weapons segment (+15.8%) and a significant surge in the Axon segment (+97.5%), indicating successful market adoption of their integrated hardware and software solutions for law enforcement. The company also showed improved profitability, with gross margin increasing to 65.8% and net income rising by 57.1% to $6.1 million. This was achieved despite an increase in R&D spending, particularly in the Axon segment, reflecting the company's investment in future growth. Management highlighted increased adoption of the TASER X26P and X2 smart weapons, alongside continued strong demand for Axon on-officer cameras and the Evidence.com platform as key drivers for the quarter's financial performance.

Financial Highlights

50 data points
Beta

Revenue

$46.71M

65.8% Gross Margin

Net Income

$6.10M

13.1% Net Margin

EPS (Diluted)

$0.11

Total Assets

$212.15M

Cash & Equivalents

$40.35M

Free Cash Flow

-$3.38M

Financial Statements
Beta
Revenue$46.71M
Cost of Revenue$15.99M
Gross Profit$30.72M
R&D Expenses$5.91M
SG&A Expenses$15.44M
Operating Expenses$21.35M
Operating Income$9.37M
Net Income$6.10M
EPS (Basic)$0.11
EPS (Diluted)$0.11
Shares Outstanding (Basic)53.64M
Shares Outstanding (Diluted)54.80M

Key Highlights

  • 1Net sales increased by 25.7% year-over-year to $46.7 million, driven by strong performance across both segments.
  • 2The Axon segment experienced exceptional growth, with net sales up 97.5% to $8.9 million, highlighting the increasing adoption of their technology solutions.
  • 3Gross margin improved significantly to 65.8% from 62.4% in the prior year's quarter, reflecting improved operational efficiency and product mix.
  • 4Net income grew by 57.1% to $6.1 million, with diluted EPS rising to $0.11 from $0.07.
  • 5Research and Development expenses increased by 70.9% to $5.9 million, with a substantial portion allocated to the Axon segment's new product development.
  • 6Bookings for Axon products and services showed substantial growth, increasing 170.0% to $30.6 million, indicating a strong future revenue pipeline.
  • 7The company maintains a healthy balance sheet with $40.4 million in cash and cash equivalents and $46.3 million in short-term investments, and has $7.0 million available under its revolving credit facility.

Frequently Asked Questions

Revenue growth was driven by strong demand for both TASER smart weapons, particularly the X26P and X2 models, and the rapidly expanding Axon segment, which includes on-officer cameras and the Evidence.com cloud-based evidence management platform. The Axon segment saw exceptional growth of 97.5% year-over-year.

The company increased its R&D expenses by 70.9% to $5.9 million, with a significant portion allocated to the Axon segment to support new product development and enhance existing offerings. Despite this investment, overall operating expenses as a percentage of net sales remained stable, and gross margins improved, indicating effective cost management and scaling benefits.

Bookings for Axon products and services surged by 170.0% to $30.6 million for the quarter. This substantial increase in bookings suggests a very strong future revenue pipeline for the Axon segment, reinforcing management's focus on this growth area.

TASER International maintained a strong liquidity position with approximately $99.0 million in cash, cash equivalents, and investments as of June 30, 2015. The company also has a $10.0 million revolving credit facility with $7.0 million available, providing ample financial flexibility for operations and strategic initiatives.